首页> 外文期刊>Renal failure. >The correlation of inflammatory markers and plasma vaspin levels in patients with diabetic nephropathy
【24h】

The correlation of inflammatory markers and plasma vaspin levels in patients with diabetic nephropathy

机译:糖尿病肾病患者炎症标志物与血浆vaspin水平的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Vaspin, a recently identified adipokine, is a visceral adipose tissue-derived serine protease inhibitor that may have insulin sensitizing effect on adipose tissue. Herein, we measured vaspin level in patients with different stages of diabetic nephropathy (DNP), and investigated the correlation of the vaspin level with other inflammatory parameters. 106 adult type 2 diabetic patients with no known chronic inflammatory disease were included and grouped according to the stage of DNP: Albuminuria <30mg/day and estimated glomerular filtration rate (eGFR)>60mL/min/1.73m(2) (Group-1); albuminuria 30-300mg/day and eGFR >60mL/min/1.73m(2) (Group-2); albuminuria >300mL/min and eGFR <60mL/min/1.73m(2) (Group-3). Demographic, clinical and laboratory data were recorded as well as vaspin, high sensitivity C-reactive protein (hsCRP), interleukin (IL)-1 and tumor necrosis factor (TNF)- levels. There were 38, 35 and 33 patients in Group 1, 2 and 3, respectively. Groups were similar regarding age and gender. Vaspin level did not differ between groups. When all the groups were considered, vaspin was positively correlated with IL-6 level (r=0.215, p=0.041). No correlation of vaspin was found with IL-1, TNF- and hsCRP levels (p=0.580, r=0.054; p=0.463, r=0.072; p=0.812, r=0.025, respectively). Vaspin levels of the patients with GFR 60mL/min/1.73m(2) was less than that of patients with GFR <60mL/min/1.73m(2) (p=0.03). Age and IL-6 were found to be the major determinants of vaspin level with linear regression analysis. In patients with DNP, vaspin level does not change within the early stages of DNP; while it is higher in patients with decreased GFR, which may be related with increasing inflammation regardless of the stage of the kidney disease.
机译:Vaspin是最近发现的一种脂肪因子,是一种内脏脂肪组织衍生的丝氨酸蛋白酶抑制剂,可能对脂肪组织具有胰岛素增敏作用。本文中,我们测量了糖尿病肾病(DNP)不同阶段患者的vaspin水平,并研究了vaspin水平与其他炎症参数的相关性。纳入106例没有已知慢性炎症性疾病的成人2型糖尿病患者,并根据DNP的阶段进行分组:白蛋白尿<30mg /天,估计肾小球滤过率(eGFR)> 60mL / min / 1.73m(2)(第1组) );蛋白尿30-300mg /天,eGFR> 60mL / min / 1.73m(2)(Group-2);蛋白尿> 300mL / min和eGFR <60mL / min / 1.73m(2)(Group-3)。记录了人口统计学,临床和实验室数据以及vaspin,高敏C反应蛋白(hsCRP),白介素(IL)-1和肿瘤坏死因子(TNF)-水平。第1、2和3组分别有38、35和33例患者。在年龄和性别方面,各组相似。两组之间的Vaspin水平无差异。当考虑所有组时,vaspin与IL-6水平呈正相关(r = 0.215,p = 0.041)。没有发现vaspin与IL-1,TNF-和hsCRP水平相关(分别为p = 0.580,r = 0.054; p = 0.463,r = 0.072; p = 0.812,r = 0.025)。 GFR 60mL / min / 1.73m(2)患者的Vaspin水平低于GFR <60mL / min / 1.73m(2)患者(p = 0.03)。通过线性回归分析,发现年龄和IL-6是vaspin水平的主要决定因素。在DNP患者中,vaspin水平在DNP的早期阶段不会改变;而肾小球滤过率降低的患者则更高,这可能与炎症增加有关,而与肾脏疾病的阶段无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号